Navigation Links
Onyx Pharmaceuticals Announces Data Presentations Highlighting Carfilzomib at 53rd American Society of Hematology Annual Meeting
Date:11/7/2011

ion: Myeloma - Therapy, excluding Transplantation: Combinations Therapy for Myeloma
  • Abstract #631

  • Carfilzomib Combined with Thalidomide and Dexamethasone (CARTHADEX) as Induction Treatment Prior to High-Dose Melphalan in Newly Diagnosed Patients with Multiple Myeloma, a Trial of the European Myeloma Network

    • Dr. Pieter Sonneveld, Erasmus Medical Center, Rotterdam, Netherlands
    • Monday, December 12, 3:15 – 3:30 p.m., Ballroom 20D
    • Oral Session: Myeloma - Therapy, excluding Transplantation: Combinations Therapy for Myeloma
    • Abstract #633

    Unfavorable Cytogenetic Characteristics Do Not Adversely Impact Response Rates in Patients with Relapsed and/or Refractory Multiple Myeloma Treated with Single-Agent Carfilzomib on the 003-A1 Study

    • Dr. Andrzej Jakubowiak, University of Chicago
    • Saturday, December 10, 2011, 5:30 – 7:30 p.m., Hall GH
    • Poster session: Myeloma - Therapy, excluding Transplantation: Poster I
    • Abstract #1875

    Integrated Safety Data from Phase 2 Studies of Monotherapy Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma: An Updated Analysis

    • Dr. Seema Singhal, Northwestern University Feinberg School of Medicine
    • Saturday, December 10, 2011, 5:30 – 7:30 p.m., Hall GH
    • Poster session: Myeloma - Therapy, excluding Transplantation: Poster I
    • Abstract #1876

    Multivariate Modelling Reveals Evidence of a Dose-Response Relationship in Phase 2 Studies of Single-Agent Carfilzomib

    • Dr. Pierre Squifflet, International Drug Development Institute, Louvain-la-Neuve, Belgium
    • Saturday, December 10, 2011, 5:30 – 7:30 p.m., Hall GH
    • Poster session: Myeloma - Therapy, excluding Transplantation: P
      '/>"/>

    SOURCE Onyx Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Anadys Pharmaceuticals Reports Third Quarter 2011 Financial Results and Highlights
    2. Planet Biopharmaceuticals, Inc. Divests Assets of Allergy Control Products, Inc.
    3. Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results
    4. Savient Pharmaceuticals Announces New Data Surrounding KRYSTEXXA® and the Impact of Refractory Chronic Gout at the American College of Rheumatology Meeting
    5. Vanda Pharmaceuticals Reports Third Quarter 2011 Results
    6. Quanticel Pharmaceuticals Enters Into Strategic Cancer Drug Discovery Collaboration With Celgene Corporation
    7. Cadence Pharmaceuticals Reports Third Quarter 2011 Financial Results
    8. Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results
    9. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2011 Financial Results
    10. Onyx Pharmaceuticals Reports Third Quarter 2011 Financial Results
    11. Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2011 Financial Results and Provides Pipeline Update
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/1/2015)... September 1, 2015 BerGenBio AS ... announces that it has appointed Hilde Furberg ... to its Board of Directors, effective immediately. ... experience in pharma and biotech and is currently Senior ... company. Previously her role was Vice President and General ...
    (Date:9/1/2015)... 1, 2015  Valeant Pharmaceuticals International, Inc. (NYSE: ... that its affiliate has entered into a collaboration ... an exclusive license to develop and commercialize brodalumab. ... monoclonal antibody in development for patients with moderate-to-severe ... Valeant will hold the exclusive rights to develop ...
    (Date:8/31/2015)... PHOENIX , Aug. 31, 2015  DICOM ... announced today that it was recognized as a ... Radiology software.  The awards are sponsored ... and related professionals in the medical imaging industry.  ... for radiology professionals to acknowledge the contributions of ...
    Breaking Medicine Technology:BerGenBio Appoints Non-Executive Directors 2Valeant And AstraZeneca To Partner On Brodalumab 2Valeant And AstraZeneca To Partner On Brodalumab 3Valeant And AstraZeneca To Partner On Brodalumab 4DG Suite Nabs "Minnies" Nomination for "Best New Radiology Software" 2
    ... 2012   Syndax Pharmaceuticals, Inc. and Ventana Medical ... an agreement to develop a companion diagnostic assay to ... treatment with erlotinib and Syndax,s proprietary lead molecule entinostat.  ... Ventana, a world leader and innovator of tissue-based diagnostic ...
    ... (Nasdaq: VRNM ), a leading industrial biotechnology ... enzymes, today announced the introduction of VEREFLOW™ alpha-amylase, a ... drilling operations.  This high performance enzyme effectively removes filter ... on the face of the wellbore, the hole drilled ...
    Cached Medicine Technology:Syndax Pharmaceuticals Signs Agreement with Ventana Medical Systems, Inc. to Develop Companion Diagnostic Test for Entinostat 2Syndax Pharmaceuticals Signs Agreement with Ventana Medical Systems, Inc. to Develop Companion Diagnostic Test for Entinostat 3Syndax Pharmaceuticals Signs Agreement with Ventana Medical Systems, Inc. to Develop Companion Diagnostic Test for Entinostat 4Verenium Launches Second Enzyme Product for Oilfield Services 2Verenium Launches Second Enzyme Product for Oilfield Services 3
    (Date:9/1/2015)... ... September 01, 2015 , ... ... Archiver for Alfresco, a next-generation customer communications archiving solution integrated with Alfresco‘s ... technology from Crawford and helps organizations save millions of dollars in printing ...
    (Date:9/1/2015)... ... September 01, 2015 , ... Routines… every family has ... can help make things easier for parents, caregivers and children too. Here are three ... both big and small become more fluid. When a routine is implemented into a ...
    (Date:9/1/2015)... ... 01, 2015 , ... The premier online medical education company ... leader in podiatric, surgical and wound care conferences . The Residency Education ... speakers at the podium and across the table during hands-on surgical and advanced ...
    (Date:8/31/2015)... ... August 31, 2015 , ... Jvion, the Atlanta-based leader in ... case focused on helping hospital perform under the Center for Medicare & Medicaid ... adjusted based on performance across four domains related to care quality. To receive ...
    (Date:8/31/2015)... , ... August 31, 2015 , ... Southern Vacation Rentals ... has teamed up with fellow South Walton property management company, 360 Blue, ... poverty in remote parts of the world. The two companies will collect any unopened ...
    Breaking Medicine News(10 mins):Health News:Introducing Next-Generation Archiving Solution PRO Archiver for Alfresco® 2Health News:Introducing Next-Generation Archiving Solution PRO Archiver for Alfresco® 3Health News:Back into the Swing of Things: How Family Routines Benefit Children 2Health News:PRESENT e-Learning Systems Announces their 2016 Podiatry and Wound Care Medical Education Conference Schedule 2Health News:Jvion Releases Value-Based Purchasing Predictive Use Case 2Health News:Southern Vacation Rentals Partners with the Sonder Project 2Health News:Southern Vacation Rentals Partners with the Sonder Project 3
    ... the 66th Annual Meeting of the American Academy ... ... AGI Dermatics presented,clinical research that indicates the 8-oxo-guanine DNA glycosylase (OGG1),encapsulated ... DNA repair, reducing MMP-1 secretion and increasing,collagen production in UV irradiated ...
    ... Uroplasty, Inc. (Amex:,UPI), a medical device company ... for the treatment of voiding dysfunction,announced today ... minimally invasive nerve stimulation device, designed for,office-based ... be,featured in three presentations at the Society ...
    ... Feb. 11 /PRNewswire-FirstCall/ - Neurochem Inc. (NASDAQ:,NRMX; TSX: ... 2008, Dr.,Francesco Bellini, Neurochem,s Chairman, President and Chief ... of the new,nutraceutical business, will present Neurochem,s strategy ... be held at the Waldorf-Astoria, in New York,(NY). ...
    ... bedside manner as better informed patients make ever-increasing demands ... in clinical decisions that directly affect their care. ... Related Research, Dr. J. Bohannon Mason of the Orthocarolina ... at the changes in society, the population and technology ...
    ... incidence of malignancy, so women with this condition can ... to a new study by a team of researchers ... A fibroadenoma is a benign growth of the breast ... usually associated with breast cancer, and are often diagnosed ...
    ... 2008 Researchers at Pulmonary Associates today announced ... for Emphysema) Trial, an international, multi-center clinical trial ... a new, minimally invasive option for those suffering ... airway bypass, a catheter-based bronchoscopic procedure designed to ...
    Cached Medicine News:Health News:AGI Dermatics Data Indicates 8 Oxo-Guanine Repair Enzyme OGG1 Encapsulated in Liposomes, Reduces MMP-1, Increases Collagen and Enhances DNA Repair 2Health News:AGI Dermatics Data Indicates 8 Oxo-Guanine Repair Enzyme OGG1 Encapsulated in Liposomes, Reduces MMP-1, Increases Collagen and Enhances DNA Repair 3Health News:Studies on Urgent(R) PC to be Presented at the 2008 Society of Urologic Nurses and Associates Annual Symposium 2Health News:Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live 2Health News:Doctor who? Are patients making clinical decisions? 2Health News:Study finds patients with complex fibroadenomas can avoid surgery 2Health News:Researchers at Pulmonary Associates to study airway bypass procedure for severe emphysema 2
    FLEXILOG spare part....
    Complete calibration kits are available for both pH and manometry systems....
    Flexilog custom medical carts are configured to suite the requirements of FLEXILOG motility system users. With locking wheels and storage drawers, our carts are suitable for any care provider in any ...
    ... kit for convenient pH catheter calibration., ,pH ... any procedure. The Alpine Calibration kit contains ... water for your convenience. Simply cut the ... catheters to soak. No measuring or pouring! ...
    Medicine Products: